[This review was originally posted at the Nieman Journalism Lab Cephalexin Over The Counter, on April 20, 2012.]
The Pulitzers and HuffPo’s arrival: The Pulitzer Prizes were awarded this week, accompanied as usual by tears and impromptu speeches in newsrooms around the country (documented well by Jeff Sonderman on Storify). On the meta-level, the Washington Post’s Erik Wemple criticized the awards’ secrecy, but Dean Starkman of the Columbia Journalism Review offered a defense of having such publicly celebrated industry awards in the first place, arguing that during an era when news organizations have become so adept at measuring journalism quantity, the Pulitzers are one of the few barometers left for journalism quality, get Cephalexin.
As for this year’s awards themselves, the American Journalism Review’s Rem Rieder pointed out that while the Pulitzers are usually dominated by a few heavy hitters, this year brought several feel-good stories. One of those was the Pulitzer won by the Philadelphia Inquirer, Buy cheap Cephalexin no rx, the once-great paper that has had an extremely rough last several years and was sold yet again for a bargain-basement price just a few weeks ago. Poynter’s Steve Myers reported on the award’s impact, which one reporter called “a wonderful burst of hope.”
Another remarkable Pulitzer winner was Sara Ganim of the Patriot News of Harrisburg, Pennsylvania, who at 24 became one of the youngest Pulitzer winners ever for her reporting on the Penn State sex abuse scandal. Poynter’s Mallary Tenore explained how she took the lead on the story at two different papers, Cephalexin Over The Counter. Not all the news was heartwarming, Cephalexin canada, mexico, india, though — there was no prize for editorial writing. Erik Wemple explained why (nothing personal!), but Gawker’s Hamilton Nolan loved the decision, calling editorials “a worthless anachronism in this modern media age.”
But the biggest theme in this year’s Pulitzers was the prominence of online journalism: The online-only Huffington Post and the very online-centric Politico both won prizes, Cephalexin online cod, which the Lab’s Adrienne LaFrance called a victory for their fast-paced, aggressive editorial models. Additionally, Twitter played a big role in the tornado coverage that earned Alabama’s Tuscaloosa News a Pulitzer, as Poynter’s Jeff Sonderman detailed.
Of those online-oriented Pulitzers, order Cephalexin online c.o.d, the Huffington Post’s drew the bulk of the attention. HuffPo’s Michael Calderone and Poynter’s Mallary Tenore Cephalexin Over The Counter, both told the story behind HuffPo’s award-winning story, and in an AP story, Ken Doctor called it an arrival of sorts for HuffPo, while VentureBeat’s Jolie O’Dell called it a win for quality blogs everywhere. PaidContent’s Staci Kramer said HuffPo’s win shows the old guard has finally learned that the work, not the medium, is the message. Order Cephalexin from mexican pharmacy, Both GigaOM’s Mathew Ingram and NYU prof Jay Rosen (in Calderone’s article) pointed out that this isn’t as much of a “new media vs. old media” win as people might think; traditional news orgs and digital outfits have been looking more and more alike for quite some time now.
There was also quite a bit of other talk about HuffPo’s model this week, though most of it wasn’t directly related to the Pulitzers. Media blogger Andrew Nusca expressed his frustration with the parade of “awful posts and shameless slideshows” that populates most of HuffPo and its competitors, and the Columbia Journalism Review published an in-depth story on how HuffPo developed its distinctive model and why it works. Meanwhile, the Lab’s Justin Ellis wrote on HuffPo’s refusal to employ false balance when covering climate change and Folio reported on its coming magazine iPad app, Cephalexin Over The Counter.
Amazon under fire: A week after the U.S, purchase Cephalexin. Justice Department sued Apple and five major book publishers for antitrust violations (paidContent’s Laura Hazard Owen has a good description of what it means for readers), most of the attention shifted to the biggest ebook player not involved in the lawsuit: Amazon. The New York Times reported on a small publisher that has removed its titles from Amazon out of frustration that the retailer’s low prices were undercutting its own booksellers.
CNET’s Greg Sandoval talked to other small publishers who see Amazon as a much bigger threat than Apple, Get Cephalexin, and at the Daily, Timothy Lee urged the U.S. government Cephalexin Over The Counter, to change copyright law to allow Amazon’s competitors to convert Kindle books to be compatible with other devices. The New York Times’ David Carr gave the most ominous warning of Amazon’s below-cost ebook pricing’s effect on the publishing industry, saying that with the suit, “Now Amazon has the Justice Department as an ally to rebuild its monopoly and wipe out other players.”
Novelist Charlie Stross went into the economics of Amazon’s ebook strategy, comparing it to big-box retailers that wipe out mom-and-pop stores with their extremely low pricing: “Amazon has the potential to be like that predatory big box retailer on a global scale, Cephalexin overnight. And it’s well on the way to doing so in the ebook sector.” Forbes’ Tim Worstall pushed back against Stross’ characterization, arguing that Amazon doesn’t have a monopoly on the ebook market because it’s still extremely easy to put ebooks on a server, achieve some scale and contest Amazon’s dominance.
Amazon’s Jeff Bezos, Cephalexin from mexico, for his part, released a letter to shareholders last Friday that asserted that “even well-meaning gatekeepers slow innovation.” Techcrunch’s John Biggs said this philosophy makes sense in the world of networked information, but Wired’s Tim Carmody said Amazon is really trying to draw a contrast between its own infrastructure-based model and the product-based “gatekeeping” model of its chief competitor, Apple.
Elsewhere, Ross Douthat of the New York Times used Google’s recently unveiled Project Glass, Herbal Cephalexin, which would bring all the information of a smartphone in front of our eyes in the form of glasses, as a warning against the possibility of a sort of hyper-surveillance techno-tyranny. Web philosopher Stowe Boyd ripped Douthat’s assertion that Google’s glasses are a reflection of our growing loneliness. (Slate’s Eric Klinenberg wrote a more thorough takedown of the “we’re getting lonelier” hypothesis, targeting Atlantic’s recent article on Facebook.) And late last week, Google’s news products chief, Cephalexin pharmacy, Richard Gingras wrote at the Lab about the questions that will define the future of journalism.
— Facebook has begun testing “trending articles” as a way to get more people to use its social news apps, though ReadWriteWeb’s Jon Mitchell said those apps, No prescription Cephalexin online, and the “frictionless sharing” they depend on, aren’t working. Cephalexin Over The Counter, Meanwhile, the Atlantic’s Alexis Madrigal said it’s time to get past the Facebook mentality of social networking and figure out what’s next for the Internet.
— NYU prof Jay Rosen wrote about a fascinating question that’s been puzzling him for years — Why does the American public trust the press so much less than it used to? — positing a few possible explanations and asking for more ideas. You can also hear Rosen talking about the state of the media and the public in this Radio Open Source podcast.
— Two more intriguing entries on the ongoing series of posts on how people get their news, these from News.me: Digital media researcher danah boyd, buy cheap Cephalexin no rx, who talked about young people’s news consumption, and former New York Times digital chief Martin Nisenholtz, who talked about the Times’ transition into a digital world.
— Finally, the Times’ Brian Stelter wrote a thoughtful piece on the fleeting nature of today’s information environment, and the ephemeral, hyperactive common conversation it gives us.
Similar posts: Bactrim Cost. Tramadol For Sale. Order Retin A. Buy Lipitor without prescription. Bactrim interactions. Effects of Lipitor.
Trackbacks from: Cephalexin Over The Counter. Cephalexin Over The Counter. Cephalexin Over The Counter. Buy cheap Cephalexin. Cephalexin price. What is Cephalexin.
[This review was originally posted at the Nieman Journalism Lab Buy Armour No Prescription, on April 13, 2012.]
Facebook scoops up Instagram: There were two billion-dollar deals in the tech world this week, and by far the bigger of the two was Facebook’s purchase of the photo-sharing app Instagram. Mathew Ingram of GigaOM has a good, quick roundup of initial reaction to the deal, but I’ll try to sort through each of the angles to the story, including what this means for Facebook, Instagram, and the tech world in general. Buy Armour online cod, The first big question was why Facebook bought Instagram, especially for so much money. The most common answer, voiced most persuasively by GigaOM’s Om Malik, was that Facebook felt threatened by Instagram’s ascendance in mobile photo sharing, one area in which Facebook has struggled. Business Insider’s Nicholas Carlson explained why Instagram does mobile photos so much better than Facebook, and Fortune’s Dan Primack suggested that Facebook panicked at all the money Instagram has raised recently, Armour maximum dosage.
The New York Times also characterized the deal as a big move by Facebook into mobile media, but there were other key aspects at work, too: Ingram said Instagram’s value lay in its network, and Wired’s Tim Carmody said what matters to Facebook is Instagram’s personal data, Buy Armour No Prescription. Rackspace’s Robert Scoble outlined some of the specifics of that data, and All Things Digital’s Lauren Goode focused on Instagram’s location data. New York’s Paul Ford said Facebook is attempting to buy Instagram’s sincerity: “Remember what the iPod was to Apple. That’s how Instagram might look to Facebook: an artfully designed product that does one thing perfectly.”
So what does this mean for Instagram. TechCrunch detailed the company’s rise, and the big concern was, Ordering Armour online, as CNN’s John Sutter put it, whether Facebook would “ruin” Instagram. Mashable’s Christina Warren urged Facebook Buy Armour No Prescription, to keep Instagram mobile-only and keep it separate from Facebook logins, and Jolie O’Dell of VentureBeat pointed out some of the good things Facebook’s developers could do for Instagram. TechCrunch noted that Facebook’s statement that it would keep Instagram as a separate product is a big departure from Facebook’s unified approach.
That concern over Facebook ruining Instagram indicates a certain revulsion for Facebook among Instagram users, something Om Malik took note of. Forbes’ John McQuaid said the sentiments reveal our uneasiness with the utility-like role tech giants like Facebook are playing in our new social world, and The Next Web’s Courtney Boyd Myers reminded Instagram users that the fact that they loved it so much was a big part of the reason it got bought in the first place.
The next question was for the tech industry as a whole: Does Instagram’s massive purchase price signal another tech market bubble, online Armour without a prescription. The Atlantic’s Rebecca Greenfield said it’s just time to accept the existence of a social media bubble, and the Guardian’s Charles Arthur said we may not be at the peak of inflated valuations, though also at the Guardian, Dan Gillmor said we could be near the end of the bubble, Buy Armour No Prescription. But Wired’s Andy Baio crunched the numbers and said Instagram wasn’t overvalued, and if anything, the tech market is rewarding efficiency. Forbes’ Robert Hof, meanwhile, looked at whether we’ll see more social media purchases soon, Armour schedule, coming up with some reasons for a slowdown.
Finally, Poynter’s Jeff Sonderman looked at some of the ways journalists have used Instagram, and Reuters’ Jack Shafer put the deal in the context of the larger cultural shift from voice to text to images. “So, Instagram is here,” he said. “What I want to know is: Where is it going to take us?”
Buy Armour No Prescription, Apple, publishers, Amazon, and ebooks’ future: The ebook industry absorbed a blow this week when the U.S. Department of Justice sued Apple and five of the largest book publishers for antitrust violations involving price-fixing for ebooks, cheap Armour. (Sixteen states also filed a lawsuit of their own.) Three of the publishers — Hachette, Simon & Schuster, and HarperCollins — immediately settled with the DOJ, and Wired’s Tim Carmody explained the terms of the settlement, which will undermine the model that the publishers created with Apple, though not kill it outright. Armour duration, Apple, Penguin, and Macmillan have decided not to settle, and the latter’s CEO issued a defiant letter in response to the suit.
PaidContent’s Laura Hazard Owen wrote a fantastic explanation of what the case is about, but in short, the issue centers on what’s called agency pricing, in which the publishers set book prices, Armour blogs, rather than the retailers, and the books must be at the same price across retailers. In 2010, Apple negotiated an agency pricing model with the big book publishers for the rollout of its iPad’s iBookstore, and the DOJ objected to that as price-fixing, Buy Armour No Prescription.
The Verge’s Nilay Patel dug through more of the details from the lawsuit of the alleged price-fixing process, particularly its response to Amazon’s perceived ebook dominance. At the same time, however, Buy generic Armour, as Peter Kafka of All Things Digital noted, Apple was allegedly considering a deal to divide and share rulership over online content with Amazon. A few people said the DOJ wasn’t likely to win the suit: Law prof Richard Epstein said the agency pricing arrangement has more social and consumer benefits than a classic collusion case, and CNET concluded that Apple should be able to win its case, too. Adam Thierer of the Technology Liberation Front put the strategy in the context of copyright challenges, coming out against the suit in the process. Buy Armour No Prescription, Also this week, we found out that several of the big publishers have refused to sign their annual contracts with Amazon, as Salon’s Alexander Zaitchik reported and Laura Hazard Owen explained. The Seattle Times has been running a critical series on Amazon, Armour gel, ointment, cream, pill, spray, continuous-release, extended-release, which, as the Los Angeles Times pointed out, includes some real concern about Amazon behaving anti-competitively by selling ebooks for too little.
Publishers have argued that that’s why agency pricing is necessary: It’s the best chance to keep Amazon from undercutting publishers and laying waste to the book industry. Web thinker Tim O’Reilly said the government should be watching Amazon more closely than the five companies it just sued, but Nate Hoffelder of The Digital Reader defended Amazon, Online buying Armour, arguing that it’s helping enable an entirely new publishing model in its stead.
Christopher Mims of Technology Review said it doesn’t matter if Amazon becomes a monopoly. And GigaOM’s Mathew Ingram also said Amazon’s practices have been good for consumers and good for innovation, unlike those of the publishers: “They seem to have spent most of their time dragging their feet and throwing up roadblocks to any kind of innovation … Their defense of the agency-pricing model feels like yet another attempt to stave off the forces of disruption, Buy Armour No Prescription. Why not try to adapt instead?”
Others had more personal stories: The legendary investigative reporter Seymour Hersh, longtime Philly television columnist Gail Shister, j-prof Dan Kennedy, and The Wrap’s Sharon Waxman, Buy Armour No Prescription. As Kennedy wrote: “I really do think there was a golden age of television news, and Wallace was right in the middle of it.”
— A few more takes on last week’s purchase of the Philadelphia Inquirer and Daily News by a group of local investors: The New York Times’ David Carr mused on the return of the newspaper baron, the American Journalism Review’s John Morton examined the recent spree of newspaper purchases in a downtime for the industry, Purchase Armour online no prescription, and Penn prof Victor Pickard argued for more systemic solutions to save papers like Philly’s.
— A couple of interesting pieces from the academic view of journalism: NYU’s Jay Rosen and MIT’s Ethan Zuckerman talked about trends in journalism at an MIT forum (summarized well by Matt Stempeck), and CUNY’s C.W. Anderson talked a bit about his research on data journalism to Tyler Dukes of Reporters’ Lab.
— The debate over the value of online commenting continues: Animal’s Joel Johnson proposed that comments are worth far less than publishers think, because they don’t draw many readers and don’t make money, but GigaOM’s Mathew Ingram countered that comments are an important check on online authority and that not allowing them tells readers to “go away.”
— News analyst Alan Mutter made the age-old argument that newspapers are failing in their digital efforts in a brief, potent piece decrying newspapers’ poor digital products and weak competitive response, and urging them to pool their efforts.
— Finally, Digital First Media’s Steve Buttry wrote a gracious but no-nonsense letter to newsroom curmudgeons defending digital journalism practices, then wrote about what he learned from its fallout, then addressed the role of news organizations themselves in enabling curmudgeonhood. The posts and comments are a good glimpse into the current state of newsroom culture and change.
Similar posts: Retin A Mg. Buy Diflucan No Prescription. Synthroid For Sale. Discount Glucophage. Get Synthroid. Tramadol pics.
Trackbacks from: Buy Armour No Prescription. Buy Armour No Prescription. Buy Armour No Prescription. Low dose Armour. Order Armour from United States pharmacy. Armour gel, ointment, cream, pill, spray, continuous-release, extended-release.